Please login to the form below

Not currently logged in
Email:
Password:

Fluzone Quadrivalent

This page shows the latest Fluzone Quadrivalent news and features for those working in and with pharma, biotech and healthcare.

Sanofi to pay $750m for vaccines biotech Protein Sciences

Sanofi to pay $750m for vaccines biotech Protein Sciences

Sanofi’s vaccines portfolio already includes the four-in-one influenza vaccine Fluzone Quadrivalent, which the FDA approved in June 2013.

Latest news

  • AZ wins EU approval for four-strain flu vaccine AZ wins EU approval for four-strain flu vaccine

    It follows the approval earlier this year of GlaxoSmithKline's (GSK) four-strain, or quadrivalent, influenza vaccine Influsplit Tetra/Fluarix Tetra as pharma companies look to shift towards vaccines that provide ... Both AZ and GSK won approvals for

  • GSK gets OK for second quadrivalent flu vaccine in US GSK gets OK for second quadrivalent flu vaccine in US

    GSK gets OK for second quadrivalent flu vaccine in US. FDA approves Flulaval Quadrivalent. ... GSK joined the club when its Fluarix Quadrivalent was approved by the FDA last December, and since then Sanofi has also been given a green light for its

  • FDA approves Sanofi's four-in-one flu vaccine FDA approves Sanofi's four-in-one flu vaccine

    Sanofi Pasteur, the vaccines division of Sanofi, received a recommendation for its Fluzone Quadrivalent vaccine for use in children six months of age and older, adolescents, and adults to protect against ... According to Sanofi, the Fluzone Quadrivalent

  • GSK’s four-strain flu vaccine approved in Germany and UK GSK’s four-strain flu vaccine approved in Germany and UK

    GlaxoSmithKline (GSK) has been granted marketing approval in Germany and the UK for its four-strain (quadrivalent) influenza vaccine, the first registered product of its type in Europe. ... Sanofi Pasteur also has its own candidate, Fluzone Quadrivalent,

  • GSK's four-strain flu vaccine debuts in the US GSK's four-strain flu vaccine debuts in the US

    GSK's four-strain flu vaccine debuts in the US. Fluarix Quadrivalent protects against two influenza A and two influenza B subtypes. ... AstraZeneca's Medimmune division won FDA approval for its four-strain vaccine FluMist Quadrivalent in March, 2012,

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics